STOCKHOLM,Jan. 28,2025 -- The Nomination Committee of ABElectrolux proposes election of Yannick Fierling,the new President and CEO of AB Electrolux,as new member of the Board of Directors of AB Electrolux at its Annual General Meeting on March 26,2025. The Committee also proposes re-election of Torbjörn Lööf (Chair),Geert Follens,Petra Hedengran,Ulla Litzén,Daniel Nodhäll,Karin Overbeck,David Porter and Michael Rauterkus.
As previously communicated,Yannick Fierling has succeeded Jonas Samuelson as President and CEO of AB Electrolux on January 1,2025. As Jonas Samuelson also has resigned from the Board,Yannick Fierling is accordingly proposed as a new Board member.
The Nomination Committee's proposal means that the Board of Directors shall comprise nine ordinary members elected by the Annual General Meeting,without deputies.
The Nomination Committee's motivated statement,complete proposals,and a presentation of the proposed Board members will be published in due time before the Annual General Meeting 2025.
The Nomination Committee of AB Electrolux comprises Christian Cederholm,Investor AB (Chair),Marianne Nilsson,Swedbank Robur Funds,Anders Hansson,AMF Tjänstepension och Fonder,and Carina Silberg,Alecta. The Nomination Committee also include Torbjörn Lööf,Chair of the Board of AB Electrolux.
For more information,please contact:
Oscar Stjerngren,Investor Relations,+46 70 879 87 69
Electrolux Group Press Hotline,+46 8 657 65 07
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/electrolux-group/r/president-and-ceo-yannick-fierling-proposed-as-new-board-member-of-ab-electrolux,c4096250
The following files are available for download:
https://mb.cision.com/Main/1853/4096250/3226348.pdf
250128 PR Nomination committe proposal
SHANGHAI,March 17,2025-- Singapore Treasure Carbon TechPte. Ltd. (SGTC) and CHCC Capital (Singapore) Pte. Ltd. have jointly launched a fund that will invest in international carbon credit assets compl
HANGZHOU,China,March 17,2025--Chance Pharmaceuticals ("Chance Pharma"),a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies,to
Six new models announced for AI-enhanced gaming,streaming,and creation with 8K visuals and optimized thermal design with triple FrostBlade 4.0 cooling fans
SHANGHAI,March 3,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors